$BARKBearishHigh

Bark (NYSE:BARK) Misses Q1 CY2026 Sales Expectations

Bark (NYSE: BARK) reported Q1 CY2026 sales of $86.57M, below analyst estimates of $95.2M, a 25% year-on-year decline. Adjusted EPS was $0.07 versus -$0.40 expected, and adjusted EBITDA was $3.17M versus $814K expected. Q2 CY2026 revenue guidance is $78M (midpoint), below $105M estimates; FY2027 EBITDA guidance is $8.5M (midpoint).

9/10
9/10
High
Bearish
after-hours / next-session reaction to Q1 results and Q2 guidance
Guidance shortfall likely conflicts with any optimism from adjusted EPS/EBITDA beats.

Revenue miss plus below-consensus Q2 guidance, despite adjusted EPS/EBITDA beats, shifts focus to demand/trajectory risk.

Bark missed Q1 CY2026 sales expectations ($86.57M vs $95.2M) and guided Q2 revenue to $78M vs $105M estimates.

Likely downside bias as guidance shortfall can outweigh margin/EPS beats; watch for follow-through selling into next session.

Background

The piece reports Bark’s Q1 CY2026 results versus analyst estimates and provides Q2 CY2026 and FY2027 guidance.

Why it matters

Traders will likely reprice Bark on the combination of a revenue miss, below-consensus Q2 revenue guidance, and weaker operating profitability/FCF, even though adjusted EPS and EBITDA beat expectations.

Market relevance

A guidance-driven setup: Q2 revenue midpoint ($78M) is well below consensus ($105M), increasing downside risk despite adjusted profitability beats.

Market effects

Signals potential softness in the company’s demand environment, which can pressure sentiment for similarly positioned consumer/animal-related growth names.

Primarily single-name risk; limited direct regional spillover implied by the text.

No global macro or cross-border drivers mentioned beyond company-specific guidance.

Alternative perspectives

Adjusted EPS and EBITDA beats suggest cost discipline; if investors believe the revenue miss is temporary, the stock could stabilize after the initial guidance shock.

The article highlights free cash flow deterioration and worsening operating margin, which may indicate structural issues beyond near-term sales timing.

Key entities

  • Bark

    Reports Q1 CY2026 sales miss and issues Q2 CY2026 revenue guidance below consensus; also provides FY2027 EBITDA guidance above consensus.

Related articles

$RXTMedAI 8/10

Rackspace Technology Inc (RXT) Q2 2026 Earnings Call Highlights: Strategic Shift Towards AI...

Rackspace Technology’s Q2 2026 earnings call discussed AI GPU capacity plans. CFO Mark Marino said two-thirds of GPU demand is expected from new customers and revenue per megawatt should be $15M to $20M, with a $10M floor and above 50% EBITDA margins. FY26 guidance: revenue $2.45B to $2.55B, EBITDA $285M to $295M. The company also announced a $250M at-the-market equity offering for GPU growth.

$AMDMed

AMD Stock Is Up 160% in 2026 and Analysts Still Love It

AMD reported non-GAAP gross margin up 1 point to 55%, non-GAAP operating income up 43% YoY to $2.54B, and non-GAAP EPS up 43% to $1.37, above the $1.30 Street estimate. For Q2 (Aug. 4), AMD guided revenue ~$11.20B (+/- $300M) and non-GAAP gross margin ~56%. Analysts raised price targets and reiterated bullish views.

$DALMed

Why Delta trades less like an airline and more like a loyalty business

Delta Air Lines (DAL) reported June-quarter results that beat estimates and kept its full-year adjusted EPS guidance at $6.50 to $7.50. Adjusted fuel expense rose 77% to $4.4B as jet fuel averaged $3.93/gallon. Adjusted operating revenue was $17.7B (+14%). Premium revenue (+17%) and loyalty (+19%) helped offset margin pressure; GAAP net income fell 25% to $1.6B.

$MUMedAI 8/10

Micron Stock’s Sell-Off Won't Last. Here’s the Simple Reason Why.

Micron Technology’s valuation is debated, with forward GAAP P/E at 13.05 versus a 33.19 sector median, while forward P/S is 8.27 versus its 5-year average of 3.93. After Q3 FY2026 results, revenue rose to $41.46B and non-GAAP EPS to $25.11. Q4 guidance calls for ~$50B revenue and non-GAAP EPS ~$31. Analysts raised price targets, including Baird to $1,280 and JPM to $1,540.